Pages that link to "Q36702203"

The following pages link to Proteomics in clinical interventions: achievements and limitations in biomarker development (Q36702203):

Displaying 10 items.

• Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas (Q28728855) (← links)
• High-throughput proteomics using antibody microarrays: an update (Q33300137) (← links)
• Toxicological protein biomarker analysis--an investigative one-week single dose intravenous infusion toxicity and toxicokinetic study in cynomolgus monkeys using an antibody-cytotoxic conjugate against ovarian cancer (Q33308781) (← links)
• Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration (Q33357303) (← links)
• Use of proteomics for the discovery of early markers of drug toxicity. (Q34698617) (← links)
• The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research (Q36667345) (← links)
• Key developments in endocrine disrupter research and human health (Q37119910) (← links)
• Omics in mechanistic and predictive toxicology (Q37677046) (← links)
• Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis (Q38021940) (← links)
• Use of proteomics for the discovery of early markers of drug toxicity (Q54246969) (← links)